👍👍👍
#Prevention&Intervention#AISN#Symico#ShockwaveWorkshop Thank you all for being with us on Friday during P&I Congress and Workshop 👍
Agencja Naukowo - Techniczna "SYMICO"
Handel detaliczny
Bringing the most innovative solutions in cardiac surgery, interventional cardiology, radiology & vascular surgery
Informacje
"Symico" represents high-quality medical solutions from world-leader manufacturers in the field of cardiac surgery, interventional cardiology, electrophysiology, radiology & vascular surgery since 21 years, covering terrority of Poland. We are representing: Atricure (USA), Shockwave Medical (USA), LeMaitre (USA), QMedics (Switzerland), Cardionovum (Germany), VenusMedtech (China), APT Medical (China) in EP Field, Helena Laboratories (USA), Terumo - for Off-Pump solutions, Shunmei Medical (China) & many others.
- Branża
- Handel detaliczny
- Wielkość firmy
- 11–50 pracowników
- Siedziba główna
- Wrocław
- Rodzaj
- Spółka cywilna
- Data założenia
- 2002
Lokalizacje
-
Główna
Otrzymaj wskazówki o trasie dojazdu
Powstańców Śląskich
54a/2
53-333 Wrocław, PL
Pracownicy Agencja Naukowo - Techniczna "SYMICO"
-
Dorota B.
President / Managing Director Agencja Naukowo - Techniczna "Symico" Sp. z o.o.
-
Agata Wojcik
Sales & Marketing Director "Symico" Sp z o.o.
-
Ilona Malewicz
Medical Devices ENDOVASCULAR
-
Katarzyna Mielnik
Specjalista ds. Administracyjno-Biurowych w Agencja Naukowo-Techniczna „Symico” Sp. z o.o.
Aktualizacje
-
#EHRA#Atricure##Convergent#Symico What a great day at EHRA Berlin Congress. Today Symico - as an exclusive distributor of Atricure - took part in CME-Accredited Symposium - “ Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice” supported by AtriCure, Inc. 👍 Great discussions from internationally renowned speakers on how Hybrid AF™ Therapies can be safe & effective for persistent and longstanding persistent AF patients. *****************************************
-
-
#XIVKonferencjaSekcjiWadWrodzonychSercaUMlodocianychIDoroslych#Symico#VenusMedtech Today Agencja Naukowo - Techniczna "SYMICO" sponsored Lunch Symposium during 14th Conference of Section of Congenital Heart Defects in Adolescents and Adults. We were presenting Venus Medtech Europe first experiences with P-Valve system after MDR approval, showing our implant data collected from 2022 among the world by Klaus Runge. Very special thanks to Prof. Elzbieta Katarzyna Biernacka and Prof. Marcin Demkow for sharing their experiences with PValve performed in National Institute of Cardiology, Warsaw. 👍 We would also like to thank Ass. Prof. Magdalena Lipczynska for PTK Section invitation for this event. The VenusP-Valve System is the first self-expanding nitinol stent for pulmonary valve in Europe, designed at 28-36 mm for valve diameter specifically for large RVOTs.
-
-
#BestDistributorAward#Atricure#Symico Receiving awards from a business partner is an amazing sign of recognition. Especially in case of long - time cooperation, as we are happy to have with AtriCure, Inc. We are very proud to announce Symico received “Best Distributor” Award for 2023!!! 🥇👍 This wouldn’t be possible if not our amazing customers and their trust in AF and LAAM Treatment technology, that is now Class 1A recommendation 🫀
-
-
#SCCSZabrze#VenusMedtech#FirstImplants Yesterday SCCS in Zabrze has performed first 2 TPVI cases with P-Valve system by Venus Medtech Europe 👍🏻 distributed by Agencja Naukowo - Techniczna "SYMICO" Congratulations to all Team Members, especially to Ass. Prof. Roland Fiszer and Dr Michał Gałeczka for their great performance 👏🏻 👏🏻👏🏻 Special thanks to Sir Shakeel Qureshi for being with us! Looking forward to our next meeting and successful implantations!!! 🫀🫀🫀 The VenusP-Valve System was designed at 28-36 mm valve diameters, specifically for large RVOTs. The intended purpose of VenusP-Valve is to replace the pulmonary heart valve with an artificial valve using a minimally invasive percutaneous approach, to treat right ventricular outflow tract (RVOT) dysfunction and specifically for the dilated outflow tracts to restore pulmonary valve function.
-